Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer

Despite growing appreciation of the importance of epigenetics in breast cancer, our understanding of epigenetic alterations of non-coding RNAs (ncRNAs) in breast cancer remains limited. Here, we explored the epigenetic patterns of ncRNAs in breast cancers using published sequencing-based methylome data, primarily focusing on the two most commonly studied ncRNA biotypes, long ncRNAs and miRNAs. We observed widely aberrant methylation in the promoters of ncRNAs, and this abnormal methylation was more frequent than that in protein-coding genes. Specifically, intergenic ncRNAs were observed to comprise a majority (51.45% of the lncRNAs and 51.57% of the miRNAs) of the aberrantly methylated ncRNA promoters. Moreover, we summarized five patterns of aberrant ncRNA promoter methylation in the context of genomic CpG islands (CGIs), in which aberrant methylation occurred not only on CGIs, but also in regions flanking CGI and in CGI-lacking promoters. Integration with transcriptional datasets enabled us to determine that the ncRNA promoter methylation events were associated with transcriptional changes. Furthermore, a panel of ncRNAs were identified as biomarkers that discriminated between disease phenotypes. Finally, the potential functions of aberrantly methylated ncRNAs were predicted, suggestiong that ncRNAs and coding genes cooperatively mediate pathway dysregulation during the development and progression of breast cancer.

[1]  J. Komorowski,et al.  Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. , 2008, Molecular cell.

[2]  Jean Qiu,et al.  The metabolic demands of cancer cells are coupled to their size and protein synthesis rates , 2013, Cancer & Metabolism.

[3]  F. Lyko,et al.  Methylation of Human MicroRNA Genes in Normal and Neoplastic Cells , 2007, Cell cycle.

[4]  Louisa Flintoft,et al.  Non-coding RNA: Structure and function for lncRNAs , 2013, Nature Reviews Genetics.

[5]  Zheng Li,et al.  MicroRNA dysregulation in uveal melanoma: a new player enters the game , 2015, Oncotarget.

[6]  Louisa Flintoft,et al.  Evolution: Speciation meets microbiomes , 2013, Nature Reviews Genetics.

[7]  C. Gong,et al.  Long non‐coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival , 2013, Cancer science.

[8]  Luigi Ferrucci,et al.  Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain , 2010, PLoS genetics.

[9]  Hiromu Suzuki,et al.  DNA methylation and microRNA dysregulation in cancer , 2012, Molecular oncology.

[10]  Timothy J. Durham,et al.  Systematic analysis of chromatin state dynamics in nine human cell types , 2011, Nature.

[11]  C. Sander,et al.  Analysis of microRNA-target interactions across diverse cancer types , 2013, Nature Structural &Molecular Biology.

[12]  Brian S. Roberts,et al.  Recurrent read-through fusion transcripts in breast cancer , 2014, Breast Cancer Research and Treatment.

[13]  Brian J. Stevenson,et al.  Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. , 2012, Genome research.

[14]  Lee T. Sam,et al.  Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. , 2011, Genome research.

[15]  W. Cho OncomiRs: the discovery and progress of microRNAs in cancers , 2007, Molecular Cancer.

[16]  J. Mattick,et al.  Structure and function of long noncoding RNAs in epigenetic regulation , 2013, Nature Structural &Molecular Biology.

[17]  Peng Huang,et al.  Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. , 2011, Cancer research.

[18]  C. Ricketts,et al.  Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. , 2011, Cancer research.

[19]  Andrew D. Sharrocks,et al.  Regulation of Cell Cycle-Specific Gene Expression through Cyclin-Dependent Kinase-Mediated Phosphorylation of the Forkhead Transcription Factor Fkh2p , 2004, Molecular and Cellular Biology.

[20]  Chien-Jen Chen,et al.  Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma , 2012, Epigenetics.

[21]  Xiaoke Ma,et al.  Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks , 2012, Nucleic acids research.

[22]  Songnian Hu,et al.  A comparison between ribo-minus RNA-sequencing and polyA-selected RNA-sequencing. , 2010, Genomics.

[23]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[24]  Sampsa Hautaniemi,et al.  Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors , 2013, Genome Biology.

[25]  C. Croce,et al.  MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review , 2012, EMBO molecular medicine.

[26]  Robert A. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688)) , 2008 .

[27]  M. Jouvenot,et al.  Epigenetic regulation of estrogen signaling in breast cancer , 2013, Epigenetics.

[28]  Shuli Kang,et al.  Large-scale prediction of long non-coding RNA functions in a coding–non-coding gene co-expression network , 2011, Nucleic acids research.

[29]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[30]  I. Andrulis,et al.  Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. , 2000, Carcinogenesis.

[31]  C. Ponting,et al.  Genomic and Transcriptional Co-Localization of Protein-Coding and Long Non-Coding RNA Pairs in the Developing Brain , 2009, PLoS genetics.

[32]  S. Ariyan,et al.  Genome-wide screen of promoter methylation identifies novel markers in melanoma. , 2009, Genome research.

[33]  Christoph Bock,et al.  Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk , 2012, Genome research.

[34]  E. Gelfand,et al.  Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells. , 2004, Molecular cancer research : MCR.

[35]  Leonard Lipovich,et al.  Genome-wide computational identification and manual annotation of human long noncoding RNA genes. , 2010, RNA.

[36]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[37]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[38]  Li Fu,et al.  Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells. , 2011, Genes & cancer.

[39]  Xiaoke Ma,et al.  Long non-coding RNAs function annotation : a global prediction method based on bicolored networks , 2013 .

[40]  Brian McCue,et al.  miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer , 2012, Molecular Cancer.

[41]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[42]  E. Alba,et al.  Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer , 2010, BMC Cancer.

[43]  Bing-Hua Jiang,et al.  Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer , 2011, Clinical Cancer Research.

[44]  Chao Cheng,et al.  Transcription Factor Binding Profiles Reveal Cyclic Expression of Human Protein-coding Genes and Non-coding RNAs , 2013, PLoS Comput. Biol..

[45]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[46]  Zhen Bian,et al.  miR-29b regulates migration of human breast cancer cells , 2011, Molecular and Cellular Biochemistry.

[47]  C. Croce Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[48]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[49]  N. Hynes,et al.  Tyrosine kinase signalling in breast cancer , 2000, Breast Cancer Research.

[50]  P. Gunaratne,et al.  MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. , 2011, Cancer research.

[51]  A. Fernández-Medarde,et al.  Ras in cancer and developmental diseases. , 2011, Genes & cancer.

[52]  Martha R. Stampfer,et al.  miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer , 2013, PloS one.

[53]  Jun Yu,et al.  MicroRNA dysregulation in gastric cancer: a new player enters the game , 2010, Oncogene.

[54]  Yi Zhang,et al.  Role of H3K27 methylation in the regulation of lncRNA expression , 2010, Cell Research.

[55]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[56]  W. Cao,et al.  Integrated Analysis of Long Noncoding RNA and Coding RNA Expression in Esophageal Squamous Cell Carcinoma , 2013, International journal of genomics.

[57]  Timothy J. Durham,et al.  "Systematic" , 1966, Comput. J..

[58]  Vladimir B. Bajic,et al.  Content analysis of the core promoter region of human genes , 2003, Silico Biol..

[59]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[60]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[61]  Alexander R. Pico,et al.  Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage , 2012, Cell.

[62]  Mark S. Doderer,et al.  CMS: A Web-Based System for Visualization and Analysis of Genome-Wide Methylation Data of Human Cancers , 2013, PloS one.

[63]  C. Plass,et al.  Genome-wide epigenetic regulation of miRNAs in cancer. , 2013, Cancer research.